Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lifestyle Interventions and Propranolol in Monoclonal Gammopathies
NCT05312255Recruiting
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Jun 2022
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of propranolol in multiple myeloma (MM) (5 arms), sponsored by Roswell Park Comprehensive Cancer Center. Primary endpoint: Changes in immune cell subsets at 1 year. Started Jun 2022; status: recruiting.
02
Drugs
propranolol
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT05312255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05312255.